Last reviewed · How we verify
conventional medicine + TCM — Competitive Intelligence Brief
phase 3
Immune modulator
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
conventional medicine + TCM (conventional medicine + TCM) — Henan University of Traditional Chinese Medicine. This conventional medicine combined with TCM works by modulating the body's immune response and reducing inflammation.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| conventional medicine + TCM TARGET | conventional medicine + TCM | Henan University of Traditional Chinese Medicine | phase 3 | Immune modulator | ||
| Viral CTLs | Viral CTLs | New York Medical College | phase 3 | Immune modulator | CD8+ T cells |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Immune modulator class)
- Astellas Pharma China, Inc. · 1 drug in this class
- Henan University of Traditional Chinese Medicine · 1 drug in this class
- New York Medical College · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- conventional medicine + TCM CI watch — RSS
- conventional medicine + TCM CI watch — Atom
- conventional medicine + TCM CI watch — JSON
- conventional medicine + TCM alone — RSS
- Whole Immune modulator class — RSS
Cite this brief
Drug Landscape (2026). conventional medicine + TCM — Competitive Intelligence Brief. https://druglandscape.com/ci/conventional-medicine-tcm. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab